Intelligent-C Endoscopy Module for Real-time Detection of Colonic Lesions
iIDEAS/RTD
IIDEAS Intelligent-C Endoscopy Module for Real-time Detection of Colonic Lesions - a Prospective, Single Blinded, Non - Randomized, Single - Center Study
1 other identifier
observational
380
1 country
1
Brief Summary
To conduct an single blinded, non-randomized, prospective, single center trial to validate the performance of a novel state-of-the-art Artificial Intelligence model (AI-Model) for colorectal lesion detection during routine diagnostic colonoscopy and to evaluate its feasibility in daily endoscopy. Consecutive patients referred for a screening, surveillance or diagnostic colonoscopy will be included
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 13, 2022
CompletedStudy Start
First participant enrolled
March 20, 2023
CompletedFirst Posted
Study publicly available on registry
March 27, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2023
CompletedJanuary 27, 2025
November 1, 2023
3 months
November 13, 2022
January 23, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Performance of a novel state-of-the-art Artificial Intelligence model (AI-Model) for colorectal lesion detection during routine diagnostic colonoscopy
A single-blinded, non-randomized prospective trial to validate the performance of a novel state-of-the-art Artificial Intelligence model (AI-Model) for colorectal lesion detection during routine diagnostic colonoscopy.
1 Year
Interventions
Bowel preparation will be conducted according to usual local practices. During colonoscopy, the colonoscope will be first advanced to the cecum in all patients as confirmed by identification of the appendicular orifice and ileocecal valve or by intubation of the ileum, as per the standard of care by experienced endoscopists. During the insertion, no action will be taken. After cecal intubation is performed, the colonoscope will be slowly withdrawn to the splenic flexure by the primary endoscopists. Real time AI detection model will be activated with the output displayed in real time on a separate monitor and will be only viewed by an independent investigator, who is an experienced endoscopists (or a person trained in polyp recognition). The primary endoscopists will be blinded to the AI real time detection result
Eligibility Criteria
Our pilot series showed AI assistance can detect up to 80 % of missed lesions with sample variance at around 0.032. We hypothesize that the adenoma/polyp miss rate of conventional colonoscopy can be reduced by 50% to 75% with AI assistance. Assuming 4% patients may be excluded. The sample size is estimated to be 381 patients in total with a power of 95% and a significance level of 0.05. An interim analysis will be performed when the first 150 patients are recruited to verify the sample size estimation
You may qualify if:
- Patients undergoing colonoscopy of age 18 to 80 years.
- Consecutive adult patients scheduled to undergo routine colonoscopy at AIG
You may not qualify if:
- Females who are pregnant
- Patients who are unsuitable for any other reason to participate in the study in the opinion of the investigator
- Recent colonoscopy within past 12 month
- History of inflammatory bowel disease
- History of colorectal cancer
- Previous bowel resection (apart from appendectomy)
- Peutz-Jeghers syndrome, familial adenomatous polyposis or other polyposis syndromes
- Bleeding tendency or severe comorbid illnesses for which polypectomy is considered unsafe.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
AIG Hospitals
Hyderabad, Telangana, 500032, India
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hardik Rughwani, MD, DM
Asian Institute of Gastroenterology
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 13, 2022
First Posted
March 27, 2023
Study Start
March 20, 2023
Primary Completion
July 1, 2023
Study Completion
November 1, 2023
Last Updated
January 27, 2025
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share